title: [Cost-benefit analysis of conservative therapy of gastritis and peptic ulcer].
authors.forename: E
authors.initials: E
authors.lastname: Schütz
authors.forename: M
authors.initials: M
authors.lastname: Stolte
mesh_terms: D000041:Absenteeism; D000900:Anti-Bacterial Agents / Q000191:economics* / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000191:economics* / Q000627:therapeutic use; D001729:Bismuth / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D005756:Gastritis / Q000188:drug therapy / Q000191:economics*; D016481:Helicobacter Infections / Q000188:drug therapy / Q000191:economics*; D016480:Helicobacter pylori / Q000187:drug effects; D006801:Humans
chemical_list: D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D001729:Bismuth
vernacular_title: Zur Kosten-Nutzen-Analyse der konservativen Therapie der Gastritis und des Ulkusleidens.